Literature DB >> 28500173

TGF-β1 (Transforming Growth Factor-β1) Plays a Pivotal Role in Cardiac Myofibroblast Arrhythmogenicity.

Nicolò Salvarani1, Ange Maguy1, Stefano A De Simone1, Michele Miragoli1, Florian Jousset1, Stephan Rohr2.   

Abstract

BACKGROUND: TGF-β1 (transforming growth factor-β1) importantly contributes to cardiac fibrosis by controlling differentiation, migration, and collagen secretion of cardiac myofibroblasts. It is still elusive, however, to which extent TGF-β1 alters the electrophysiological phenotype of myofibroblasts and cardiomyocytes and whether it affects proarrhythmic myofibroblast-cardiomyocyte crosstalk observed in vitro. METHODS AND
RESULTS: Patch-clamp recordings of cultured neonatal rat ventricular myofibroblasts revealed that TGF-β1, applied for 24 to 48 hours at clinically relevant concentrations (≤2.5 ng/mL), causes substantial membrane depolarization concomitant with a several-fold increase of transmembrane currents. Transcriptome analysis revealed TGF-β1-dependent changes in 29 of 63 ion channel/pump/connexin transcripts, indicating a pleiotropic effect on the electrical phenotype of myofibroblasts. Whereas not affecting cardiomyocyte membrane potentials and cardiomyocyte-cardiomyocyte gap junctional coupling, TGF-β1 depolarized cardiomyocytes coupled to myofibroblasts by ≈20 mV and increased gap junctional coupling between myofibroblasts and cardiomyocytes >5-fold as reflected by elevated connexin 43 and consortin transcripts. TGF-β1-dependent cardiomyocyte depolarization resulted from electrotonic crosstalk with myofibroblasts as demonstrated by immediate normalization of cardiomyocyte electrophysiology after targeted disruption of coupled myofibroblasts and by cessation of ectopic activity of cardiomyocytes coupled to myofibroblasts during pharmacological gap junctional uncoupling. In cardiac fibrosis models exhibiting slow conduction and ectopic activity, block of TGF-β1 signaling completely abolished both arrhythmogenic conditions.
CONCLUSIONS: TGF-β1 profoundly alters the electrophysiological phenotype of cardiac myofibroblasts. Apart from possibly contributing to the control of cell function in general, the changes proved to be pivotal for proarrhythmic myofibroblast-cardiomyocyte crosstalk in vitro, which suggests that TGF-β1 may play a potentially important role in arrhythmogenesis of the fibrotic heart.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  fibroblasts; gap junctions; ion channel; myocytes, cardiac; myofibroblast; transforming growth factors

Mesh:

Substances:

Year:  2017        PMID: 28500173     DOI: 10.1161/CIRCEP.116.004567

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  36 in total

Review 1.  Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).

Authors:  Niels Voigt; Fleur Mason; Dierk Thomas
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-08

2.  Is TGF-β1 (Transforming Growth Factor-β1) an Enabler of Myofibroblast-Cardiomyocyte Cross Talk?

Authors:  Kuljeet Kaur; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

3.  Inflammatory responses mediate brain-heart interaction after ischemic stroke in adult mice.

Authors:  Tao Yan; Zhili Chen; Michael Chopp; Poornima Venkat; Alex Zacharek; Wei Li; Yi Shen; Ruixia Wu; Linlin Li; Julie Landschoot-Ward; Mei Lu; Kuan-Han Hank; Jianning Zhang; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-11-22       Impact factor: 6.200

4.  Cardiomyocyte-myofibroblast contact dynamism is modulated by connexin-43.

Authors:  Francisca Schultz; Pamela Swiatlowska; Anita Alvarez-Laviada; Jose L Sanchez-Alonso; Qianqian Song; Antoine A F de Vries; Daniël A Pijnappels; Emily Ongstad; Vania M M Braga; Emilia Entcheva; Robert G Gourdie; Michele Miragoli; Julia Gorelik
Journal:  FASEB J       Date:  2019-07-05       Impact factor: 5.191

Review 5.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

Review 6.  Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors.

Authors:  Yuling Jing; Ruixue Yang; Wen Chen; Qiang Ye
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

7.  Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.

Authors:  Mary E Haywood; Andrea Cocciolo; Kadijah F Porter; Evgenia Dobrinskikh; Dobromir Slavov; Sharon L Graw; T Brett Reece; Amrut V Ambardekar; Michael R Bristow; Luisa Mestroni; Matthew R G Taylor
Journal:  J Mol Cell Cardiol       Date:  2020-01-18       Impact factor: 5.000

Review 8.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

9.  CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Zhili Chen; Michael Chopp; Alex Zacharek; Julie Landschoot-Ward; Lauren Culmone; Xiao-Ping Yang; Jiang Xu; Jieli Chen
Journal:  Transl Stroke Res       Date:  2020-03-20       Impact factor: 6.829

10.  A new model of myofibroblast-cardiomyocyte interactions and their differences across species.

Authors:  Fusheng Liu; Hou Wu; Xiaoyu Yang; Yuqin Dong; Guoyou Huang; Guy M Genin; Tian Jian Lu; Feng Xu
Journal:  Biophys J       Date:  2021-07-17       Impact factor: 3.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.